Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Jun 26, 2025 05:15PM
Cidara Announces Pricing of Upsized Public Offering of Common Stock Jun 24, 2025 08:00PM
Cidara Therapeutics (CDTX) Announces Proposed $250M Share Offering Jun 23, 2025 04:16PM
Cidara Announces Proposed Public Offering of Common Stock Jun 23, 2025 04:15PM
Cantor Fitzgerald Reiterates Overweight Rating on Cidara Therapeutics (CDTX) Jun 10, 2025 06:45AM
View Older Stories

Apr 15, 2025 06:59AM Cantor Fitzgerald Reiterates Overweight Rating on Cidara Therapeutics (CDTX)
Jan 27, 2025 08:47AM Cantor Fitzgerald Assumes Cidara Therapeutics (CDTX) at Overweight
May 11, 2023 04:37PM Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
Mar 31, 2023 08:00AM Cidara Therapeutics to Participate in Upcoming Investor Conferences
Mar 23, 2023 07:13AM Cidara Therapeutics (CDTX) Provides Corporate Update, Reports Q4
Mar 23, 2023 07:12AM Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Mar 7, 2023 04:01PM Cidara Therapeutics Announces Closing of Public Offerings of Common Stock and Preferred Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares in Public Offering of Common Sto
Mar 3, 2023 09:15AM Cidara Therapeutics (CDTX) Prices $17.5M Common and Preferred Stock Offering
Mar 3, 2023 09:14AM Cidara Therapeutics Announces Pricing of Public Offerings of Common Stock and Preferred Stock
Mar 2, 2023 04:15PM Cidara Therapeutics (CDTX) Announces Proposed Stock Offering
Mar 2, 2023 04:14PM Cidara Therapeutics Announces Underwritten Public Offerings of Common Stock and Preferred Stock
May 12, 2022 06:21AM Cantor Fitzgerald Reiterates Overweight Rating. $5 Price Target on Cidara Therapeutics (CDTX), "We Believe Street Under-appreciated Sales Potential of CDTX's Two Pipeline Assets"
Mar 8, 2022 05:58AM Cantor Fitzgerald Reiterates Cidara Therapeutics (CDTX) at Overweight, Believes the Street Underappreciates Company's Sales Potential, Sees Upward Earnings Revisions
Feb 17, 2022 05:55AM Johnson & Johnson (JNJ), Cidara Therapeutics (CDTX), Pfizer (PFE), and PDS Biotechnology (PDSB) - Cantor Fitzgerald's Top Flu Vaccine Candidates for 2022
Oct 13, 2021 04:01PM Cidara Therapeutics Announces Closing of Concurrent Public Offerings of Common Stock and Preferred Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of
Oct 13, 2021 04:01PM Cidara Therapeutics Announces Closing of Concurrent Public Offerings of Common Stock and Preferred Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of
Oct 8, 2021 09:13AM Cidara Therapeutics (CDTX) Prices 14.84M Share Offering at $1.55/sh
Oct 8, 2021 09:12AM Cidara Therapeutics Announces Pricing of Concurrent Public Offerings of Common Stock and Preferred Stock
Oct 8, 2021 09:12AM Cidara Therapeutics Announces Pricing of Concurrent Public Offerings of Common Stock and Preferred Stock
Oct 7, 2021 04:01PM Cidara Therapeutics (CDTX) Commences Concurrent Public Offerings of Common Stock and Preferred Stock
Oct 7, 2021 04:01PM Cidara Therapeutics Announces Commencement of Concurrent Public Offerings of Common Stock and Preferred Stock
Oct 7, 2021 04:01PM Cidara Therapeutics Announces Commencement of Concurrent Public Offerings of Common Stock and Preferred Stock
Nov 5, 2020 04:24PM Cidara Provides Corporate Update and Reports Third Quarter 2020 Financial Results
Nov 5, 2020 04:23PM Cidara Provides Corporate Update and Reports Third Quarter 2020 Financial Results
Sep 2, 2020 08:00AM Cidara Therapeutics to Participate in Upcoming Investor Conferences
Sep 2, 2020 08:00AM Cidara Therapeutics to Participate in Upcoming Investor Conferences
Aug 13, 2020 04:48PM Cidara Provides Corporate Update and Reports Second Quarter 2020 Financial Results
Aug 13, 2020 04:48PM Cidara Provides Corporate Update and Reports Second Quarter 2020 Financial Results
Jun 23, 2020 08:00AM Cidara Therapeutics to Participate in Cantor Fitzgerald Virtual Symposium: Winning Ways to Treat Infections and COVID-19
Jun 23, 2020 08:00AM Cidara Therapeutics to Participate in Cantor Fitzgerald Virtual Symposium: Winning Ways to Treat Infections and COVID-19
Jan 27, 2020 01:44PM Cidara Therapeutics (CDTX) Halted on Volatility After Surge Higher
Jan 27, 2020 01:07PM Cantor Fitzgerald Highlights Cidara Therapeutics (CDTX) on Coronavirus Opportunity
Jan 10, 2020 08:01AM Cidara Therapeutics (CDTX) Announces Proposed $30M Rights Offering
Jan 10, 2020 08:00AM Cidara Therapeutics Announces Proposed Rights Offering
Jun 12, 2019 11:13AM Cidara Therapeutics (CDTX) PT Lowered to $8 at Cantor Fitzgerald
May 21, 2018 07:38AM Cidara Therapeutics (CDTX) Announces Offering of Common Stock, Warrants
May 21, 2018 07:30AM Cidara Therapeutics Announces Offering of Common Stock and Warrants
Oct 19, 2017 09:01AM Cidara Therapeutics (CDTX) Prices $20M Private Placement of Common Stock
Oct 19, 2017 09:00AM Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock
Sep 18, 2017 04:05PM Cidara Therapeutics to Present at Two Upcoming Conferences
Jun 26, 2017 02:45AM Cantor Fitzgerald Assumes Cidara Therapeutics (CDTX) at Overweight, Sees Underappreciated Sales Potential
Oct 28, 2016 08:06AM Cantor Fitzgerald Starts Cidara Therapeutics (CDTX) at Buy
Oct 13, 2016 09:20AM Cidara Therapeutics Announces Closing of Public Offering of Common Stock, Including Exercise of Underwriter’s Option to Purchase Additional Shares
Oct 7, 2016 09:04AM Cidara Therapeutics (CDTX) Prices 2.48M Common Stock Offering at $10.10/Share
Oct 7, 2016 09:00AM Cidara Therapeutics Announces Pricing of Public Offering of Common Stock
Oct 6, 2016 04:02PM Cidara Therapeutics (CDTX) to Offer Common Stock
Oct 6, 2016 04:02PM Cidara Therapeutics Announces Commencement of Public Offering of Common Stock
Jul 6, 2016 07:00AM Cidara Therapeutics to Present at the Cantor Fitzgerald Annual Healthcare Conference
View Older Stories